Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio

International Journal of Cancer

Volumn 136, Issue 5, 2015, Pages 1234-1240

  Ferroni, Patrizia ^a   Riondino, Silvia ^b   Formica, Vincenzo ^b   Cereda, Vittore ^b   Tosetto, Livia ^b   La Farina, Francesca ^c   Valente, Maria Giovanna ^c   Vergati, Matteo ^b   Guadagni, Fiorella ^a   Roselli, Mario ^b  

^a IRCCS SAN RAFFAELE PISANA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c San Raffaele Foundation Ceglie Messapica Hospital   (Italy)

Author keywords

Chemotherapy; Inflammation; Neutrophils; Platelets; Venous thromboembolism

Indexed keywords

BEVACIZUMAB;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL LYMPHOCYTE RATIO; OUTPATIENT; PLATELET LYMPHOCYTE RATIO; PREDICTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL TIME; VENOUS THROMBOEMBOLISM; ADOLESCENT; AMBULATORY CARE; COMPLICATION; FOLLOW UP; LYMPHOCYTE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; NEUTROPHIL; PATHOLOGY; PROGNOSIS; THROMBOCYTE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; BLOOD PLATELETS; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; NEUTROPHILS; PROGNOSIS; RISK FACTORS; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 84918775397     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29076     Document Type: Article

References (25)

1. Khorana AA, Dalal M, Lin J, et al. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States. Cancer 2013;119:648-55.
2. Lowe GD. Virchow's triad revisited: abnormal flow. Pathophysiol Haemost Thromb 2003;33:455-7.
3. Balkwill FR, Mantovani A. Cancer-related inflammation: common themes and therapeutic opportunities. Semin Cancer Biol 2012;22:33-40.
4. Candido J, Hagemann T. Cancer-related inflammation. J Clin Immunol 2013;33:S79-84.
5. Rak J, Yu JL, Luyendyk J, et al. Oncogenes, trousseau syndrome, and cancer-related changes in the coagulome of mice and humans. Cancer Res 2006;66:10643-6.
6. Khorana AA, Kuderer NM, Culakova E, et al. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 2008;111:4902-7.
7. Li DB, Hua Q, Liu Z, et al. Association between inflammatory mediators and angiographic morphologic features indicating thrombus formation in patients with acute myocardial infarction. Chin Med J (Engl) 2009;122:1738-42.
8. Ertaş G, Sönmez O, Turfan M, et al. Neutrophil/lymphocyte ratio is associated with thromboembolic stroke in patients with non-valvular atrial fibrillation. J Neurol Sci 2013;324:49-52.
9. Gürsoy OM, Karakoyun S, Kalçik M, et al. Usefulness of novel hematologic inflammatory parameters to predict prosthetic mitral valve thrombosis. Am J Cardiol 2014;113:860-4.
10. Bakirci EM, Topcu S, Kalkan K, et al. The role of the nonspecific inflammatory markers in determining the anatomic extent of venous thromboembolism. Clin Appl Thromb Hemost 2013. DOI: 10.1177/1076029613494469.
11. Paramanathan A, Saxena A, Morris DL. A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours. Surg Oncol 2014;23:31-9.
12. Baranyai Z, Krzystanek M, Jósa V, et al. The comparison of thrombocytosis and plateletlymphocyte ratio as potential prognostic markers in colorectal cancer. Thromb Haemost 2014;111:483-90.
13. Krenn-Pilko S, Langsenlehner U, Thurner EM, et al. The elevated preoperative platelet-tolymphocyte ratio predicts poor prognosis in breast cancer patients. Br J Cancer 2014;110:2524-30.
14. Go SI, Lee A, Lee US, et al. Clinical significance of the neutrophil-lymphocyte ratio in venous thromboembolism patients with lung cancer. Lung Cancer 2014;84:79-85.
15. Roselli M, Ferroni P, Riondino S, et al. Impact of chemotherapy on activated protein C-dependent thrombin generation-association with VTE occurrence. Int J Cancer 2013;133:1253-8.
16. Gibson PH, Cuthbertson BH, Croal BL, et al. Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 2010;105:186-91.
17. Von Brühl ML, Stark K, Steinhart A, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012;209:819-35.
18. Blix K, Jensvoll H, Brækkan SK, et al. White blood cell count measured prior to cancer development is associated with future risk of venous thromboembolism-the Tromsø study. PLoS One 2013;8:e73447.
19. Demers M, Wagner DD. Neutrophil extracellular traps: a new link to cancer-associated thrombosis and potential implications for tumor progression. Oncoimmunology 2013;2:e22946.
20. Demers M, Krause DS, Schatzberg D, et al. Cancers predispose neutrophils to release extracellular DNA trapsthat contribute to cancer-associated thrombosis. Proc Natl Acad Sci USA 2012;109:13076-81.
21. Savchenko AS, Martinod K, Seidman MA, et al. Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development. J Thromb Haemost 2014;12:860-70.
22. Simanek R, Vormittag R, Ay C, et al. High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). J Thromb Haemost 2010;8:114-20.
23. Jensvoll H, Blix K, Brækkan SK, et al. Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø study. PLoS One 2014;9:e92011.
24. Heits F, Katschinski DM, Wilmsen U, et al. Serum thrombopoietin and interleukin 6 concentrations in tumour patients and response to chemotherapy-induced thrombocytopenia. Eur J Haematol 1997;59:53-8.
25. Lyman GH, Khorana AA, Kuderer NM, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol 2013;31:2189-204.